Rhumbline Advisers Caribou Biosciences, Inc. Transaction History
Rhumbline Advisers
- $105 Billion
- Q2 2024
A detailed history of Rhumbline Advisers transactions in Caribou Biosciences, Inc. stock. As of the latest transaction made, Rhumbline Advisers holds 124,915 shares of CRBU stock, worth $343,516. This represents 0.0% of its overall portfolio holdings.
Number of Shares
124,915
Previous 122,517
1.96%
Holding current value
$343,516
Previous $629,000
67.57%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding CRBU
# of Institutions
140Shares Held
52.6MCall Options Held
32.5KPut Options Held
89.8K-
Black Rock Inc. New York, NY6.95MShares$19.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.54MShares$12.5 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC4.16MShares$11.4 Million0.0% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA4.08MShares$11.2 Million0.34% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.34MShares$6.44 Million0.01% of portfolio
About Caribou Biosciences, Inc.
- Ticker CRBU
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,840,800
- Market Cap $167M
- Description
- Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...